QA specialist
CK Group is recruiting for a QA Specialist (GMP) to join a global pharmaceutical company on a contract basis for 9 months.
Salary:
Paying up to £20 per hour PAYE
QA Specialist Role:
- Review all batch and test documentation associated with investigational medicinal products (IMPs) and packaging components.
- Support in the investigation of non-conformances and quality incidents.
- Resolve and documents any deviation or problem relating to the audit of documents.
- Track and trend deviation investigations and CAPA.
- Review client and label vendor specifications in accordance with relevant regulatory requirements.
- Review and approve vendor-generated label proofs/specifications and other related documents.
- Educated to Degree level qualification, ideally in a science-based subject
- Relevant and extensive experience in the pharmaceutical industry.
- Labelling experience in the pharmaceutical industry is highly desirable.
- Ability to understand and apply regulatory and CGMP principles.
- Good understanding of pharmaceutical or medical terminology
- Proficiency in standard office technology, including Microsoft Suite (Outlook, PowerPoint, Excel)
- Good knowledge of rigorous pharmaceutical and/or scientific documentation practices and change control processes (e.g., revision control) is preferred.
Our client is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. They have the goal of putting patients first and to help people around the world live better and healthier lives.
Location:
This role is based at our clients site in Chester, but allows for 50/50 hybrid working (50% from home, 50% from office)
Apply:
For more information, or to apply for this QA Specialist please contact the Key Accounts Team on 01438 870011 or email pharmacontracts@ckagroup.co.uk. Please quote reference 157676.
It is essential that applicants hold entitlement to work in the UK
Please note:
This role may be subject to a satisfactory basic Disclosure and Barring Service (DBS) check.